Literature DB >> 8551589

Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus.

T Wrona1, J P Dudley.   

Abstract

C57BL/6 mice are resistant to C3H mouse mammary tumor virus (MMTV)-induced mammary tumorigenesis and lack major histocompatibility complex class II I-E molecules that are essential for presentation of C3H superantigen to T cells. T cells are needed for transmission of milk-borne MMTV from the gut to the mammary gland. In this report, we show that infectious C3H MMTV is produced by C57BL/6 mice that nurse on C3H mothers but that virus production in the mammary gland is delayed compared with that in I-E+ mouse strains.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8551589      PMCID： PMC189937     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  14 in total

Review 1.  Interaction between viral and genetic factors in murine mammary cancer.

Authors:  J Hilgers; P Bentvelzen
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

2.  A standardized nomenclature for endogenous mouse mammary tumor viruses.

Authors:  C Kozak; G Peters; R Pauley; V Morris; R Michalides; J Dudley; M Green; M Davisson; O Prakash; A Vaidya
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission.

Authors:  W Held; G A Waanders; A N Shakhov; L Scarpellino; H Acha-Orbea; H R MacDonald
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

4.  A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.

Authors:  Y Choi; J W Kappler; P Marrack
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

5.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.

Authors:  J M Penninger; V A Wallace; E Timms; T W Mak
Journal:  Eur J Immunol       Date:  1994-05       Impact factor: 5.532

7.  Quantitative estimation of mouse mammary tumor virus (MTV) antigens by radioimmunoassay;.

Authors:  A A Verstraeten; R Van Nie; H G Kwa; P C Hageman
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

8.  Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.

Authors:  T V Golovkina; A Chervonsky; J P Dudley; S R Ross
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

9.  Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.

Authors:  W Held; A N Shakhov; S Izui; G A Waanders; L Scarpellino; H R MacDonald; H Acha-Orbea
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model.

Authors:  O Karapetian; A N Shakhov; J P Kraehenbuhl; H Acha-Orbea
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307
View more
  11 in total

1.  An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.

Authors:  Susan R Ross; John W Schmidt; Elad Katz; Laura Cappelli; Stacy Hultine; Phyllis Gimotty; John G Monroe
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

Authors:  Melissa Kane; Laure K Case; Christine Wang; Leonid Yurkovetskiy; Stanislav Dikiy; Tatyana V Golovkina
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

4.  A novel mechanism of resistance to mouse mammary tumor virus infection.

Authors:  T V Golovkina
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.

Authors:  T J Wrona; M Lozano; A A Binhazim; J P Dudley
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.

Authors:  A Barnett; F Mustafa; T J Wrona; M Lozano; J P Dudley
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Lessons Learned from Mouse Mammary Tumor Virus in Animal Models.

Authors:  Jaquelin P Dudley; Tatyana V Golovkina; Susan R Ross
Journal:  ILAR J       Date:  2016

8.  Gradual elimination of retroviruses in YBR/Ei mice.

Authors:  Cameron C MacDearmid; Laure K Case; Christa L Starling; Tatyana V Golovkina
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens.

Authors:  Sanchita Bhadra; Mary M Lozano; Shelley M Payne; Jaquelin P Dudley
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

10.  Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies.

Authors:  Alexandra Purdy; Laure Case; Melody Duvall; Max Overstrom-Coleman; Nilah Monnier; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.